1-231374016-T-A
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_ModerateBP6BP7BS2
The NM_022051.3(EGLN1):c.975A>T(p.Thr325Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000477 in 1,613,666 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. T325T) has been classified as Likely benign.
Frequency
Consequence
NM_022051.3 synonymous
Scores
Clinical Significance
Conservation
Publications
- erythrocytosis, familial, 3Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- autosomal dominant secondary polycythemiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hemoglobin, high altitude adaptationInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- hereditary pheochromocytoma-paragangliomaInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| EGLN1 | NM_022051.3 | c.975A>T | p.Thr325Thr | synonymous_variant | Exon 2 of 5 | ENST00000366641.4 | NP_071334.1 | |
| EGLN1 | NM_001377260.1 | c.975A>T | p.Thr325Thr | synonymous_variant | Exon 2 of 4 | NP_001364189.1 | ||
| EGLN1 | NM_001377261.1 | c.975A>T | p.Thr325Thr | synonymous_variant | Exon 2 of 4 | NP_001364190.1 | ||
| EGLN1 | XM_024447734.2 | c.975A>T | p.Thr325Thr | synonymous_variant | Exon 2 of 3 | XP_024303502.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| EGLN1 | ENST00000366641.4 | c.975A>T | p.Thr325Thr | synonymous_variant | Exon 2 of 5 | 1 | NM_022051.3 | ENSP00000355601.3 | ||
| ENSG00000287856 | ENST00000662216.1 | c.114A>T | p.Thr38Thr | synonymous_variant | Exon 4 of 7 | ENSP00000499467.1 |
Frequencies
GnomAD3 genomes AF: 0.000499 AC: 76AN: 152172Hom.: 2 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000796 AC: 2AN: 251310 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461494Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727068 show subpopulations
GnomAD4 genome AF: 0.000499 AC: 76AN: 152172Hom.: 2 Cov.: 32 AF XY: 0.000498 AC XY: 37AN XY: 74326 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Erythrocytosis, familial, 3 Uncertain:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
not specified Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at